STL Biotech
STL_Biotech
looking at $UROV Urovant's vibegron and it is hard not to compare alongside Synergy's plecanatide. (formely $SGYP, now $BHC) -Both drugs are essentially me-toos, and are/were second to market in their class.
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.